Yosemite, which funds startups and researchers focused on the disease, is targeting a total of $350 million for its second fund from high-powered investors like pharma giant Amgen and hospital ...
In Voges, I see a success story that hasn’t been loud or flashy. It has been methodical, modern and deeply effective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results